3,010
Participants
Start Date
December 18, 2023
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
P2Y12 inhibitor
The choice of P2Y12 inhibitor is left at investigator's discretion.
Aspirin
Aspirin is administered for up to 1 month after PCI at investigator's discretion
DOAC
The choice of DOAC is left at investigator's discretion.
NOT_YET_RECRUITING
UMC public, Amsterdam
RECRUITING
Hôpitaux Universitaires de Genève, Geneva
RECRUITING
Inselspital, Bern University Hospital, Department of Cardiology, Bern
NOT_YET_RECRUITING
Hartcentrum Hasselt, Hasselt
RECRUITING
Universitätsspital Basel, Basel
RECRUITING
Cardiocentro Ticino Institute, Lugano
RECRUITING
University Hospital Zürich, Zurich
NOT_YET_RECRUITING
IRCCS Humanitas, Milan
NOT_YET_RECRUITING
CHU Nîmes, Nîmes
NOT_YET_RECRUITING
Hospital Universitario Marques de Valdecilla, Santander
NOT_YET_RECRUITING
Universitätsklinikum Frankfurt/Main, Frankfurt am Main
NOT_YET_RECRUITING
Klinikum Friedrichshafen, Friedrichshafen
NOT_YET_RECRUITING
Ospedale Ferrarotto, Catania
NOT_YET_RECRUITING
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznan
NOT_YET_RECRUITING
Imperial College London, London
Sahajanand Medical Technologies Limited
INDUSTRY
Insel Gruppe AG, University Hospital Bern
OTHER